← Back to GLSI

Greenwich LifeSciences, Inc. - Common stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 11/08/2026Mar 2026Filed 11/08/2026Sep 2025Filed 01/06/2026Jun 2025Filed 11/08/2026Mar 2025Filed 11/08/2026Sep 2024Filed 14/11/2025Jun 2024Filed 14/11/2025Mar 2024Filed 14/11/2025
−$3.9−$5.7−$3.7−$3.7−$2.7−$2.7−$2.6−$2.5
−$0.27−$0.39−$0.27−$0.28−$0.21−$0.20−$0.20−$0.19
1515141313131313

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.